Melting point	125-126 ºC**
Boiling point	170.2±8.0 ºC (760 Torr
Flash point	10.0±0.0 ºC, 计算值*
Density	1.159±0.06 g/cm3 (20 º

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

p-Tolyl isocyanate derivatization for analysis of CWC-related polar degradation products by mass spectrometry.R Karthikraj et al.Analytical and bioanalytical chemistry, 406(21), 5093-5102 (2014-02-21) A novel derivatization method for the determination of Fosfomycin in human plasma by liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometric detection via phase transfer catalyzed derivatization.Theodora A Papakondyli et al.Journal of chromatography. A, 1332, 1-7 (2014-02-11) Strains of the toxic and bloom-forming Nodularia spumigena (cyanobacteria) can degrade methylphosphonate and release methane.Jonna E Teikari et al.The ISME journal, 12(6), 1619-1630 (2018-02-16) [Acyclic nucleotide analogues based on phosphonic acids].E V Efimtseva et al.Bioorganicheskaia khimiia, 24(1), 16-20 (1998-04-29) A simple LC-MS/MS method using HILIC chromatography for the determination of fosfomycin in plasma and urine: application to a pilot pharmacokinetic study in humans.Suzanne L Parker et al.Journal of pharmaceutical and biomedical analysis, 105, 39-45 (2014-12-22) Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling.Suzanne L Parker et al.Bioanalysis, 7(19), 2585-2595 (2015-10-17) Development and validation of a LC-MS/MS method for quantitation of fosfomycin - Application to in vitro antimicrobial resistance study using hollow-fiber infection model.Adarsh Gandhi et al.Biomedical chromatography : BMC, 32(6), e4214-e4214 (2018-02-21) Enhanced In Vitro Biocompatibility and Water Dispersibility of Magnetite and Cobalt Ferrite Nanoparticles Employed as ROS Formation Enhancer in Radiation Cancer Therapy.Stefanie Klein et al.Small (Weinheim an der Bergstrasse, Germany), 14(21), e1704111-e1704111 (2018-04-19)

Remarks